IRIS
MARCHI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.267
NA - Nord America 3.592
AS - Asia 2.653
SA - Sud America 636
AF - Africa 150
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.508
GB - Regno Unito 1.595
RU - Federazione Russa 902
SG - Singapore 876
CN - Cina 699
IT - Italia 668
BR - Brasile 527
VN - Vietnam 369
IE - Irlanda 358
HK - Hong Kong 227
KR - Corea 165
DE - Germania 159
FR - Francia 155
SE - Svezia 116
IN - India 99
FI - Finlandia 98
UA - Ucraina 55
ZA - Sudafrica 52
AR - Argentina 48
CA - Canada 33
BD - Bangladesh 32
TR - Turchia 32
MX - Messico 30
AT - Austria 29
NL - Olanda 29
CI - Costa d'Avorio 28
IQ - Iraq 25
PL - Polonia 24
EC - Ecuador 18
ES - Italia 16
ID - Indonesia 15
CO - Colombia 14
KE - Kenya 14
MA - Marocco 13
NG - Nigeria 12
PK - Pakistan 12
BE - Belgio 11
CZ - Repubblica Ceca 11
JP - Giappone 11
LT - Lituania 11
VE - Venezuela 10
JO - Giordania 9
UZ - Uzbekistan 9
PH - Filippine 8
SA - Arabia Saudita 8
CL - Cile 7
IR - Iran 7
IL - Israele 6
JM - Giamaica 6
OM - Oman 6
AZ - Azerbaigian 5
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CH - Svizzera 4
MY - Malesia 4
PA - Panama 4
TN - Tunisia 4
AU - Australia 3
DK - Danimarca 3
ET - Etiopia 3
GM - Gambi 3
HN - Honduras 3
KH - Cambogia 3
LV - Lettonia 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
GA - Gabon 2
GH - Ghana 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GY - Guiana 1
IM - Isola di Man 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
RS - Serbia 1
SI - Slovenia 1
Totale 11.294
Salva come PNG Salva come JPEG
Città #
Southend 1.513
Dallas 1.019
Singapore 474
Dublin 352
Santa Clara 264
Moscow 253
Hefei 251
Ashburn 228
Hong Kong 215
Chandler 174
Seoul 165
Siena 163
Fairfield 161
Beijing 160
Council Bluffs 136
Ho Chi Minh City 112
San Jose 110
Woodbridge 95
Los Angeles 84
Seattle 72
Hanoi 70
Houston 68
Dong Ket 66
Lauterbourg 63
Munich 62
The Dalles 62
Wilmington 61
Milan 57
Cambridge 54
Helsinki 49
Johannesburg 44
Rome 44
New York 40
Princeton 40
Bengaluru 39
Lappeenranta 39
Ann Arbor 38
Florence 38
Jacksonville 36
São Paulo 33
Buffalo 30
Abidjan 28
Orem 28
Shanghai 27
San Diego 26
Nuremberg 23
Redondo Beach 23
Chicago 22
Warsaw 20
Frankfurt am Main 19
San Mateo 19
Vienna 18
Livorno 17
Boardman 16
Brooklyn 16
Montreal 16
London 15
Belo Horizonte 14
Guangzhou 14
Baghdad 13
Chennai 13
Da Nang 13
Rio de Janeiro 13
Brescia 12
Portsmouth 12
Brasília 11
Mexico City 11
Abuja 10
Arezzo 10
Porto Alegre 10
Ankara 9
Baltimore 9
Brussels 9
Denver 9
Stockholm 9
Tokyo 9
Amman 8
Amsterdam 8
Bari 8
Dearborn 8
Dhaka 8
Manchester 8
Nanjing 8
Phoenix 8
Redwood City 8
San Francisco 8
Turku 8
Bogotá 7
Bắc Ninh 7
Haiphong 7
Málaga 7
Newark 7
Piscataway 7
Ribeirão Preto 7
Salt Lake City 7
Caracas 6
Casablanca 6
Düsseldorf 6
Goiânia 6
Hải Dương 6
Totale 7.751
Salva come PNG Salva come JPEG
Nome #
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 599
The virucidal potential effects of violet-blue light on influenza D virus 549
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 477
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 456
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 406
Challenges in the development of egg-independent vaccines for influenza 267
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 233
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 228
Impact of erythrocyte species on assays for influenza serology 214
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 213
Measles in pregnancy: a threat for Italian women? 203
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 189
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 186
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 185
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 179
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 173
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 169
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 167
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 165
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 164
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 164
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 163
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 162
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 153
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy 152
Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic 148
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 144
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study 143
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 143
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination 142
Seroepidemiological study of Zika virus in selected West African countries between 2007 and 2012 142
Evaluation of varicella immunity during pregnancy in apulia region, southern italy 138
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 137
Low prevalence of antibodies against pertussis in pregnant women in Italy 136
null 136
Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study 132
Emerging and Re-emerging Arboviral Diseases as a Global Health Problem 132
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study 127
Detection of Influenza D Antibodies in Dogs, Apulia Region, Italy, 2016 and 2023 127
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020 126
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 125
Seroprotection against tetanus in the Italian general population 124
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 121
Serological Evidence for Circulation of Influenza D Virus in the Ovine Population in Italy 121
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B) 119
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 119
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? 117
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 116
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 116
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: The UNICORN study 108
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility 106
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study 104
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 103
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy 103
Measles Susceptibility in Apulia: The Italian Mirror? 103
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 103
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence 102
Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review 100
Viricide activity of antimicrobial blue light (405 nm) against the SARS-CoV-2 and influenza virus 97
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 95
SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy 88
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study 87
Seroprevalence of measles antibodies in the Italian general population in 2019–2020 87
In vitro virucidal activity of mouthwashes on SARS-CoV-2 87
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing 86
Seroprevalence study of Toscana virus and viruses belonging to the Sandfly fever Naples antigenic complex in central and southern Italy 82
Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy) 78
Serological follow-up of SARS-CoV-2 asymptomatic subjects 75
SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: Epidemic circulation in Italy in the 2023/2024 season 71
Influenza D Virus Circulation Among Bovines, Swine, Equines, and Wild Boars in Italy: A Sero-Epidemiological Study 67
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination 65
High Seroprevalence of Chikungunya Virus Antibodies Among Pregnant Women Living in an Urban Area in Benin, West Africa 62
Dose-sparing effects of novel adjuvants and aluminum hydroxide on two different vaccines in a neonatal mouse model 60
Influenza D Virus: A Potential Threat for Humans? 60
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 50
Serum neutralizing activity against SARS-CoV-2 variants in hospitalized COVID-19 patients 19
Totale 11.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 0 0 0 0 0 117 105 142
2021/2022596 80 95 88 46 19 24 23 22 35 32 50 82
2022/2023559 32 80 65 64 44 93 26 49 68 14 17 7
2023/2024651 17 27 59 24 17 134 249 21 10 34 7 52
2024/20252.345 37 175 198 164 246 177 87 100 238 103 232 588
2025/20265.294 434 683 1.061 802 843 207 543 172 263 286 0 0
Totale 11.595